Two may be better than one: PD-1/PD-L1 blockade combination approaches in metastatic breast cancer

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Two Views are Better than One: Epistemic Actions May Prime

Epistemic actions are physical actions people take more to simplify their internal problem-solving processes than to bring themselves closer to an external goal state. In the video game Tetris, for instance, players routinely over-rotate falling shapes, presumably to make recognition or placement decisions faster or less error-prone. Along these lines, an experimental study was performed to tes...

متن کامل

Human Cancer Immunotherapy with PD-1/PD-L1 Blockade

The ligation of programmed cell death-1 (PD-1) to its ligands PD-L1 and PD-L2 counteracts T-cell activation, which is critical in immune tolerance. The persistent high expression of PD-1 and PD-L1 are also observed on tumor-infiltrating lymphocytes and various tumor cells, maintaining the highly suppressive microenvironment in tumor sites and promoting tumor malignancies. The blockade of PD-1 a...

متن کامل

PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer.

Immune checkpoint inhibition represents a major recent breakthrough in the treatment of malignant diseases including breast cancer. Blocking the programmed death receptor-1 (PD-1) and its ligand, PD-L1, has shown impressive antitumor activity and may lead to durable long-term disease control, especially in the triple-negative subtypes of breast cancer (TNBC). Although immune checkpoint blockade...

متن کامل

Eye Evolution: Two Eyes Can Be Better Than One

The development of our eyes is owed in part to ancestral structures which functioned in phototaxis. With the origin of bilateral annelid larva, two eyes co-evolved with neurons to improve phototaxis performance.

متن کامل

Combination Drug Delivery Approaches in Metastatic Breast Cancer

Disseminated metastatic breast cancer needs aggressive treatment due to its reduced response to anticancer treatment and hence low survival and quality of life. Although in theory a combination drug therapy has advantages over single-agent therapy, no appreciable survival enhancement is generally reported whereas increased toxicity is frequently seen in combination treatment especially in chemo...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: npj Breast Cancer

سال: 2019

ISSN: 2374-4677

DOI: 10.1038/s41523-019-0130-x